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Abstract
Background: This study used a ‘pre-post’ research design to measure the impact of the Canadian reduced ignition
propensity law on cigarette toxicity and smoking behavior among Canadian smokers.
Method: The study was conducted in Ontario, Canada over a ten-month period in 2005-2006, consisting of 4
laboratory visits (baseline N = 61, final N = 42). At Visit 1, questionnaire data and biospecimens were collected.
During the following 24 hours, participants smoked 5 cigarettes ad libitum through a topography recording device
and collected their cigarette butts. Visit 2 consisted of a questionnaire and smoking one cigarette to measure
laboratory topography values. After ten months, these procedures were repeated.
Results: Generalized estimating equations, with law status (pre and post) as a fixed within-subject factor, were
used to determine changes in behavior and biomarker exposure. Overall, there were no significant differences in
smoking topography, breath carbon monoxide, and saliva cotinine pre-post law (p>0.1). However, analyses revealed
a significant increase in the summed concentrations of hydroxyfluorene metabolites (N = 3),, and 1-hydroxypyrene
in urine, with at notable increase in hydroxyphenanthrene metabolites (N = 3) (pΣhydroxyfluorene = 0.013, 22%
increase; p1-hydroxypyrene = 0.018, 24% increase; pΣhydroxyphenanthrene = 0.061, 17% increase).
Conclusion: While the results suggest no change in topography variables, data showed increases in exposure to
three PAH biomarkers following reduced ignition propensity implementation in Canada. These findings suggest
that human studies should be considered to evaluate policy impacts.
Keywords: Reduced Ignition Propensity (RIP) Cigarettes, Smoking Topography, Polycyclic Aromatic Hydrocarbons
(PAH)
Background
Cigarette fires are the leading cause of fire related
deaths in Canada [1]. In 2002 alone, 9,414 fires were
ignited by smokers’ materials and open flames; resulting
in 688 injuries and 94 deaths [2]. In 2005, Canada
became the first country to legislate RIP (Reduced Igni-
tion Propensity) cigarettes and the second jurisdiction
following New York State’s lead in mandating fire safety
standards for all cigarettes sold in-state [3]. The Cana-
dian law requires that cigarettes self-extinguish 75% of
the time when tested under standard protocol and has
been shown to reduce the ignition propensity of cigar-
ettes [4-6]. Although Canadian law sets the standard on
the ignition propensity of cigarettes, it does not stipulate
how RIP cigarettes are achieved. While the technology
to produce RIP cigarettes has been in place within the
cigarette industry for decades [7], currently the most
common method of compliance is the use of lower por-
osity bands applied to the cigarette paper [8]. These
bands can best be described as ‘speed bumps’ that ulti-
mately aid in extinguishing the cigarette unless it is
being puffed.
Modifying cigarette design has the potential to
change the chemical composition of cigarette toxin
constituents [9] or alter an individual’ss m o k i n gb e h a -
vior and thus, nicotine and toxicant exposure [10-12].
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behavioral and chemical effects of switching smokers
to RIP versions of three popular American brand cigar-
ettes (Newport, Camel, and Marlboro). Overall, no
changes in smoking behavior were observed and,
although measurable increases in exposure to phenan-
threne were seen in smokers after switching to RIP
cigarettes, generally no significant differences in bio-
markers of exposure were identified [13]. At the same
time, the effects of RIP regulation on exposure may be
different in Canada given known differences in the
blend of tobacco and the emissions profile relative to
American cigarettes [14,15]. Cote and colleagues [16]
reported an evaluation of the impact of the Canadian
RIP regulation on smoking behavior and exposure
using ‘yield-in-use’ assessments of spent cigarette fil-
ters. They report no significant differences in tar and
nicotine exposures when comparing smokers’ samples
collected before and after the law [16]. However, the
samples tested were independent groups, rather than a
cohort. Studies utilizing cohorts of smokers may be
more conducive to evaluating effects of policy changes,
as demographic characteristics of the sample are con-
sistent over time [17].
The goal of this study was to use a ‘pre-post’ evalua-
tion design to measure the impact of the Canadian RIP
law on smoking behavior and cigarette toxicity in Cana-
dian smokers. Specifically, the study sought to take
advantage of the natural experiment presented by the
implementation of the Canadian RIP law to examine the
stability of smoking topography over a ten month time
period, pre and post RIP law. The study also examined
variations in biomarkers of exposure to nicotine and
polycyclic aromatic hydrocarbons (PAH’s) studied by
O’Connor et al. [13] before and after the RIP regulations
were put into effect.
Methods
Participants
Participants were initially recruited from July through
September 2005, prior to the implementation of
Canada’s RIP law. Eligibility criteria included being
aged 18 to 55 years, smoking at least 100 cigarettes in
their lifetime prior to the study, and having no inten-
tion to quit smoking in the next 6 months. Eligibility
was further limited to those who smoked any of four
leading Canadian brands (Players, DuMaurier, Num-
ber 7, and Peter Jackson). At the time of the study,
these brands constituted over 50% of the Canadian
market. Individuals with serious health conditions and
females who were pregnant or planning to become
pregnant were excluded from the study. Participants
were required to provide written consent to
participate.
Materials and methods
Participants were recruited from the Kitchener/Waterloo
region of Ontario, Canada for a ten month study exam-
ining behavioral and biomarker changes following the
implementation of Canada’sn e wR I Pl a w .T h es t u d y
design is illustrated in Table 1. Participants were asked
to visit the laboratory four times over a ten month per-
iod, twice pre-RIP law and twice post-RIP law. Pairs of
visits at pre and post-RIP periods were scheduled 24-
hours apart.
At visit 1, participants completed a 15-minute baseline
survey assessing demographics (age, race, and gender)
and smoking behavior with a focus on consumption for
the previous 24 hours. Questions were also asked
regarding perceptions on RIP cigarettes including taste,
fire incidents, and re-lighting of cigarettes on self-extin-
guishment. Following the survey, both saliva and urine
samples were taken as well as pre-smoking breath sam-
ples for alveolar carbon monoxide (CO) examination.
Biomonitoring was conducted prior to the field analysis
to avoid disturbance by simultaneously monitoring
smoking topography and potentially altering behavior.
Participants then smoked one cigarette and provided a
post-smoking breath sample. Finally, participants were
instructed on the procedures for the 24-hour field col-
lection period, including the use of the CReSSmicro
(Plowshare/Borgwaldt-KC, Richmond, VA) portable
topography recording device, as well as being provided
with a diary and container to store cigarette butts.
During the following 24 hours, participants were asked
to smoke at least 5 cigarettes of their normal brand ad
libitum through the CReSSmicro. They recorded the
times of each cigarette smoked in the diary and saved
each cigarette butt in the container provided in visit 1.
Participants returned to the lab the next day for visit
2, where they first completed a survey on their experi-
ences using the CReSSmicro. Next, participants smoked
one cigarette using the CReSSmicro in the presence of a
laboratory assistant. The laboratory assistant scheduled
Table 1 Study timeline for pre-post evaluation of
smoking behaviors and biomarker levels from smoking
cigarettes
Condition Pre-RIP Switch Post-RIP
Visit 1 Field 2 RIP Law Change 3 Field 4
Product NNN R R R R
Breath CO XX
Saliva Cotinine XX
Urine PAH
Metabolites
XX
Topography XX XX
N = non-compliant cigarette; R = RIP-compliant cigarette
The timeline represents the treatments given to participants on each day of
the study; Ontario, Canada, 2005-06.
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procedures which were to occur after approximately 10
months, following the implementation of the RIP laws.
Contact and back-up contact information was gathered
in order to confirm follow-up visits and participants
were given $50CDN for their time and effort. Over the
next ten months, laboratory assistants maintained con-
tact with participants via mail and phone to maximize
retention during the follow-up period.
The second half of the study followed the same
design: two laboratory visits separated by 24-hours. At
the conclusion of visit 4, participants were debriefed and
provided with an additional $50CDN for completing the
post-RIP half of the study. The study protocol received
ethics approval from the University of Waterloo and
complied with the laws of the country in which they
were performed.
Experimental: Smoking behavior, exposure biomarker,
and smoking measures
Measures for smoking behavior, exposure biomarkers,
and smoking are described in detail by O’Connor et al.
[13]. Briefly, smoking topography was assessed using the
CReSSMicro device (Borgwaldt-KC, Richmond VA).
Exhaled CO was measured after a 15-second breathhold
using a Micro+ device (Bedfont Scientific Ltd., Kent,
UK). Saliva specimens were examined for cotinine con-
centration at an outside laboratory (Salimetrics LLC,
University Park, PA). Urine specimens were measured
for concentration of hydroxylated metabolites of
naphthalene, fluorene, phenanthrene, and pyrene at the
National Center for Environmental Health, Centers for
Disease Control and Prevention, using gas chromatogra-
phy isotope dilution high resolution mass spectrometry
(GC-IDHRMS) [18]. All biospecimens were stored at
-80°C until study completion and tested simultaneously.
Participants also completed questionnaires detailing
number of cigarettes smoked as well as perceptions and
beliefs regarding cigarette fires.
Calculations
Differences in demographics and other smoking related
variables between participants were assessed using fre-
quency and descriptive measures. Changes in smoking
behavior and biomarker exposure were examined using
generalized estimating equations with law status (pre-
RIP, post-RIP) as a fixed within-subjects factor. The
model controlled for age (as a continuous variable), race
(white, other), gender (male, female), and brand (Players,
du Maurier, Number 7, and Peter Jackson). Polycyclic
aromatic hydrocarbon (PAH) biomarker concentrations
were expressed on a creatinine adjusted concentration
basis (ng/g creatinine). The concentration of PAH bio-
markers formed from the same parent compound were
summed, i.e., 1-hydroxynaphthalene (1-NAP) and 2-
NAP were summed to form naphthalene (NAP); 2-
hydroxyfluorine (2-FLUOR), 3-FLUOR, and 9-FLUOR
formed fluorine (FLUOR); and 1-hydroxyphenanthrene
(1-PHEN), 3-PHEN, and 4-PHEN formed phenanthrene
(PHEN). 1-hydroxypyrene (PYR) was analyzed singly.
Both PAH biomarkers and cotinine were natural loga-
rithm transformed pre-analysis, hence only geometric
means are reported. Statistical significance was accepted
at p<0.05, two tailed, using SPSS Version 16 (SPSS Inc.,
Chicago, IL).
Results
Participants’ characteristics
Demographic data for participants at the start of the
study can be found in Table 2. Overall, the recruitment
sample included a greater number of males to females
(54.1% to 45.9%). ‘Caucasian’ participants predominated.
The majority of participants smoked du Maurier cigar-
ettes (44.3%). Individuals were on average 32 years old,
smoking since approximately 15 years of age, an average
of 18 cigarettes per day. All participants reported smok-
ing for a minimum of four years. Though the number of
t h o s ew h oc o m p l e t e dt h ef u l ls t u d yd r o p p e db y3 1 %
(final n = 42), demographic characteristics of those who
completed the study did not differ from the recruitment
population on gender, brand, and age characteristics.
Race information was only gathered post-RIP, so only
Table 2 Demographic characteristics of recruited
participants (n = 61), Ontario, Canada, 2005-06
Variable Level Frequency Percent
Gender Male 33 54.1
Female 28 45.9
Race White 32 76.2
Other 10 23.8
Players 15 24.6
du Maurier 27 44.3
Brand Number 7 7 11.5
Peter
Jackson
9 14.5
Other 3 4.9
Mean (SD)
Age Years 32.6 (12.3)
Age began smoking Years 15.5 (2.9)
Years smoking current brand Years 8.1 (8.5)
Cigarettes per day N 18.0 (7.1)
Time to first cigarette after
waking
Minutes 39.9 (56.2)
The table represents the demographics of the sample population at baseline
by way of gender, race, brand, and age characteristics. Both raw frequency
and percent out of the whole are depicted for categorical variables and mean
values are represented for all continuous variables.
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reveal their race.
Self-reported smoking behaviors
Self-reported cigarette self-extinguishment
At baseline, more than half (51.2%) of participants
reported their cigarettes ‘never’ self-extinguished while
smoking. However, after the RIP laws were put into
effect, 24.4% reporting their cigarettes ‘never’ self-extin-
guished. These results were met by an increase in parti-
cipants reporting that their cigarettes self-extinguished
‘sometimes’ only 14.6% pre-RIP regulations to 31.7% of
the time post regulations. Overall, McNemar-Bowker’s
test revealed that difference in participants perceiving
cigarettes to self extinguish after the RIP law (reports of
Never, Sometimes, Always self-extinguishing pre vs. post
law) was not statistically significant (p = 0.092).
Cigarette consumption - cigarettes per day (CPD)
Overall, there was no significant change in cigarette
consumption before and after the RIP laws (MCPD Pre-RIP
=1 7 . 6 ,M CPD Post-RIP = 17.1). After the RIP laws were
put into effect, although minimum CPD decreased by 2
cigarettes and maximum CPD increased by 2 cigarettes,
the difference was not statistically significant (p =
0.724). After removing potential outliers, which were
defined as any change > 10 cpd in either direction, we
saw similar results (MCPD Pre-RIP =1 3 . 7 ,M CPD Post-RIP =
14.9; p = 0.191).
Smoking topography
Mean values pre and post law are shown in Table 3.
Overall, there were no significant difference between pre
and post law time periods on any topography variables.
A significant effect on puff count was observed for race
and brand, with all other individuals taking more puffs
than white participants (BOther = 2.50, p = 0.023) and
Peter Jackson smokers taking significantly fewer puffs
than Players smokers (BPeter Jackson = -4.15, p = 0.002).
A trend in race was also observed for average flow, and
statistical significance was revealed for duration of puff;
such that white participants smoked less intensively on
the measures of velocity (BOther = 4.42, p = 0.052) and
more intensively on duration of puff (BOther = -349.68, p
= 0.006). Inter-puff interval and volume, on the other
hand revealed significant differences in gender and
brand such that females waited shorter amounts of time
in between puffs compared to males (BFemales =
-3602.56, p = 0.026), but took in marginally less volume
per puff (BFemales = -8.97, p = 0.040). Peter Jackson,
Number 7, and du Maurier smokers all waited longer
amounts of time in between puffs compared to Players
smokers (BPeter Jackson = 13291.73, p < 0.001; BNumber 7 =
5629.60 p = 0.032; Bdu Maurier = 5495.17, p = 0.003).
There were no differences between any covariates on
the measure of total volume (p > 0.1). Age was not sig-
nificant association with any topography variable.
Adjusting for cotinine had no effect on any observed
topography variable.
Exposure biomarkers
Carbon monoxide (CO)
A non-significant increase in exhaled CO was shown
between the two time points. Mean values are shown in
Table 4. There was a significant difference in brand
such that participants who smoked Number 7 Reds
showed higher CO levels than participants who smoked
Players (B = 2.09, p = 0.027). There were no additional
differences in gender, race, or brand. However, we did
observe as individuals aged, their alveolar CO also
increased (Bage = 0.12; p < 0.001). As expected, total
volume of smoke was positively associated with CO (B
= 0.002, p < 0.05). Adjusting for cotinine had no effect
on observed CO.
Cotinine
We found no significant difference in cotinine after the
RIP law was put into effect. Mean values are displayed
Table 3 Model-adjusted mean smoking topography characteristics (n = 42), Ontario, Canada, 2005-06
Topography
Variable
Pre (95% CI) Post (95% CI) Change B p
Total Volume 834.9 (733.1, 936.7) 831.7 (745.8, 917.6) 0.30% -3.17 0.95
Puff Count 14.1 (12.7, 15.5) 14.2 (12.6, 15.9) 1.20% 0.17 0.815
Per Puff Volume
(mL)
59.6 (54.2, 64.9) 60.3 (54.9, 65.8) 1.30% 0.76 0.712
Puff Velocity
(mL/sec)
36.8 (33.8, 39.8) 37.2 (34.9, 39.6) 1.20% 0.45 0.738
Duration of Puff
(sec)
1.7 (1.6, 1.9) 1.7 (1.6, 1.9) 1.20% 20.66 0.719
Inter Puff Interval
(sec)
19.2 (17.0, 21.4) 17.9(15.1, 20.6) -7.20% -1376.49 0.331
Note: Model adjusted for age, gender, race/ethnicity, and brand
The above table represents the average values, percent change Pre and Post RIP compliance, B and statistical significance for all topography variables. The model
is adjusted for age, gender, race, and brand covariates. All participants who did not complete the study were excluded for analysis.
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ciation between total volume and cotinine (B = 0.001, p
< 0.05). Since smokers were free to smoke ad libitum
throughout the course of the study, we have no reason
to believe that this change could be due to alterations in
cigarette consumption directly before the study session.
Additionally, we found no significant difference in coti-
nine for any other covariates the model controlled for.
Polycyclic aromatic hydrocarbon metabolites (PAH)
R e s u l t ss h o w e ds m a l lb u ts t a tistically significant
increases in most PAH biomarker concentrations on a
creatinine adjusted concentration basis after the imple-
mentation of the RIP law. Mean values are depicted in
Table 4. Urinary metabolites of fluorene (FLUOR) and
pyrene (PYR) significantly increased at follow-up (BAfter
Lip Laws = 0.20, p = 0.013; BAfter Lip Laws = 0.21, p =
0.018), while the increase of phenanthrene (PHEN)
metabolites was notable, but nonsignificant (B = 0.15, p
= 0.061). Napthalene (NAP), FLUOR, and PHEN PAH
biomarker metabolite values revealed a significant brand
difference such that people who smoked Peter Jackson,
Number 7, and du Maurier cigarettes exhibited lower
PAH levels than Players (p < 0.05). PYR showed a signif-
icant brand difference in that Peter Jackson and Number
7 smokers exhibited lower PYR levels than Players smo-
kers (p < 0.01). Additionally, there was a marginally sig-
nificant difference by race for NAP metabolites. NAP
values were lower in all other participants than white
individuals (BOther = -0.40, p = 0.024). There were no
differences in gender, age, or topography for any bio-
marker values (p > 0.1). Further tests on the individual
NAP biomarkers revealed that, although 2-NAP
increased marginally after the RIP laws (B = 0.18, p =
0.053), 1-NAP did not (B = 0.11, p = 0.378). Summed
results were non-significant (B = 0.13, p = 0.209).
Adjusting for cotinine had no effect on findings related
to PAH biomarkers.
Discussion
The goal of this study was to examine if switching smo-
kers from conventional cigarettes to RIP - standard
cigarettes would produce a change in smoking behavior
and/or biomarker level. However, unlike an experimen-
tal switching design, this study allowed for the observa-
tion of smokers naturally adopting use of the modified
products. Any substantial change in either behavior or
biomarker value could have implications on the cigar-
ette’s health risk to the smoker. The results indicate that
the RIP cigarette design change did not lead to altera-
tions in either cigarette consumption or smoking topo-
graphy. This disconfirms the hypothesis that smokers
switching to RIP cigarettes would puff considerably
more intensively or consume more cigarettes to com-
pensate for the self-extinguishing feature of RIP compli-
ant cigarettes.
That being said, urinary PAH biomarker values were
consistently elevated after the cigarette design change
(14.3-23.5% higher), adjusting for topography and
Table 4 Model-adjusted mean saliva and urinary biomarker levels pre- and post-law, Ontario, 2005-06
Biomarker Pre (95% CI) Post (95% CI) Change B p
Breath CO (ppm)
1 4.6 (3.7, 5.4) 4.8 (3.9, 5.7) 4.3% 0.26 0.580
Saliva Cotinine
2
(ng/mL)
303.9 (242.0, 381.7) 351.1 (291.6, 422.6) 15.5% 0.14 0.126
Urine Naphthols
2
(NAP)
20046.3 (16281.8, 24681.3) 22904.8 (19809.2, 26481.5) 14.3% 0.13 0.209
(ng/g creatinine)
Urine
Hydroxyfluorenes
2
(FLUOR)
2616.3 (2121.1, 3226.7) 3196.1 (2651.3, 3852.6) 22.2% 0.20 0.013
(ng/g creatinine)
Urine
Hydroxyphenanthrenes
2
(PHEN)
469.1 (391.4, 562.3) 546.6 (458.2, 652.0) 16.5% 0.15 0.061
(ng/g creatinine)
Urine
1-hydroxypyrene
2
(PYR)
(ng/g creatinine)
162.4 (124.0, 212.7) 200.6 (155.6, 258.6) 23.5% 0.21 0.018
Notes: Means adjusted for age, gender, race/ethnicity, brand, total volume, IPI, velocity
1. Arithmetic mean
2. Geometric mean
The table above shows the geometric average values, percent change Pre and Post RIP compliance, B and statistical significance for all biomarker variables. The
model is adjusted for age, gender, race, brand, and topography covariates. All significant changes are noted by bold p values. All participants who did not
complete the study were excluded for analysis.
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xypyrene (PYR) increased significantly (22.2% and 23.5%
increase respectively). Though the increase in hydroxy-
phenanthrene (PHEN) was statistically non-significant,
there was observed a notable increase (16.5%, p =
0.061). This is a concern because of the association of
these biomarkers with benzo[a]pyrene, a known human
carcinogen. The magnitudes of change are higher than
that observed by O’Connor et al. [13] in American smo-
kers, though the mean biomarker values are in the same
range. However, unlike the American study, the
observed increases in Canada were consistent across all
biomarkers tested. These inconsistencies between stu-
dies may reflect differences in the study designs (natura-
listic versus experimental) and/or duration of
observation (10 months versus 18 days). The broader
toxicological implications of these results are unclear. At
least one study has demonstrated that there is no differ-
ence in toxicology both in vitro (genotoxicity or cyto-
toxicity) and in vivo (dermal promotion studies with
mice) between traditional and banded RIP cigarettes
[19]. In addition, While Brzeznicki and colleagues deter-
mined the half-life of urinary 1-PYR to be 9.8 hours,
half-life information on other PAH biomarkers is scarce
[20,21]. Given the OH-PAH metabolites in this study
are formed by similar biological pathways, we can sus-
pect that they also share a similar half-life to PYR [21].
Thus, we do not believe that any change in metabolites
is due to length of time between cigarette and time of
sample. However, changes in exposure levels could
reflect modifications to cigarette design that were unre-
lated to RIP laws. Tobacco companies have the opportu-
nity to change the tobacco blend and other design
characteristics of their cigarettes at any point. Further
studies are needed with a larger number of subjects
before any firm conclusions can be drawn.
Although this study allowed for observation using a
clean pre-post study design in both laboratory and nat-
ural settings, there were several limitations. A large
limitation included the lack of mainstream smoke
emissions data and toxicity reports directly assessing
differences based on design change. Though the scope
of this study was biobehavioral, future research should
examine the emissions of the cigarettes themselves and
assess the extent to which these could contribute to
altered PAH levels. This could provide further insight
into the actual toxicity of the cigarettes pre and post
RIP regulation. Second, since the final sample size was
low (N = 42), it may not be representative of the total
Canadian population of smokers. We adjusted any dif-
ferences in demographics by controlling for age, gen-
der, race, and brand of cigarette smoked. Third, our
study spanned a 10 month time period, and while par-
ticipants were still living in the Waterloo area, we
cannot guarantee that their exposures to other sources
of PAH (e.g., diet, local environment) were consistent
at both time points. Finally, we only examined leading
Canadian cigarette brands, including Peter Jackson,
Number 7, du Maurier, and Players. Since this study,
the market for contraband cigarettes smuggled into
Canada has grown considerably, particularly in
Ontario. Thus, since the gain in popularity, it may be
worthwhile to take contraband cigarettes into account.
While Health Canada testing has showed these cigar-
ettes to have similar emissions profiles as leading
brands, testing for RIP compliance has not been
reported [22].
Conclusions
Overall, we found little change in both behavior and
exhaled CO levels when switching smokers from tradi-
tional to RIP cigarettes. We did observe significant
increases in PAH biomarker levels (22.2% in FLUOR
and 23.5% in 1-PYR). Toxicological implications of these
changes are currently unknown. Although RIP cigarettes
are primarily designed to reduce fire risk, considerations
regarding heath implications of cigarette design change
should also be taken into account.
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